Abbott Receives FDA Approval For FreeStyle Libre Pro System - Quick Facts

(RTTNews) - Abbott (ABT) announced the U.S. FDA has approved the company's FreeStyle Libre Pro system, a continuous glucose monitoring system for healthcare professionals to use with their patients with diabetes. The system is designed to empower healthcare professionals to provide better diabetes management for diabetes patients.

Abbott recently submitted the consumer version of the FreeStyle Libre system for review by the U.S. Food and Drug Administration. The consumer version of the FreeStyle Libre system is designed to be a continuous glucose monitoring system that does not require fingerstick calibration.